Effects of polyamines, polyamine synthesis inhibitors, and polyamine analogs on casein kinase II using Myc oncoprotein as substrate

Biochemical Pharmacology

Volumn 58, Issue 2, 1999, Pages 251-254

  Gündoǧuş Özcanli, Nesrin ^a   Sayilir, Cafer ^b   Criss, Wayne E ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Casein kinase II; Cell proliferation; Myc; Polyamines

Indexed keywords

ARGININE; CASEIN KINASE II; DEXTRAN; DEXTRAN SULFATE; HEPARIN; ONCOPROTEIN; ORNITHINE; POLYAMINE; POLYARGININE; POLYLYSINE; POLYORNITHINE; SPERMIDINE; SPERMINE;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME KINETICS; NONHUMAN; ONCOGENE MYC; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CASEIN KINASE II; GENES, MYC; GUANOSINE TRIPHOSPHATE; KINETICS; POLYAMINES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MYC; SHEEP; SUBSTRATE SPECIFICITY;

EID: 0033566271     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00084-2     Document Type: Article

References (44)

1. Edelman A., Blumenthal D.K., Krebs E.G. Protein serine/threonine kinases. Annu Rev Biochem. 56:1987;657-713.
2. Soderling T.R. Protein kinases Regulation by autoinhibitory domains . J Biol Chem. 265:1990;1823-1826.
3. Hunter T.A. Protein kinase classification. Methods Enzymol. 200:1991;3-37.
4. Criss WE, Morishita Y, Watanabe Q, Akogyeram C, Sahi A, Deu B and Oka T, Multiple protein complex with calmodulin/polyamine-responsive protein kinase activity. In: Advances in Polyamine Research (Eds. Bachrach U, Kaye A and Chayen R), Vol. 4, pp. 657-654. Raven Press, New York, 1983.
5. Rydell E.L., Axelson K., Olsson J., Hellen S. Casein kinase II activity in malignant melanomas. Cancer Biochem Biophys. 11:1990;1987-1994.
6. Litchfield D., Luscher B. Casein kinase II in signal transduction and cell cycle regulation. Mol Cell Biochem. 127:1993;187-199.
7. 2/M. J Biol Chem. 270:1995;25905-25914.
8. Meggio F., Marchiori F., Borin G., Chessa G., Pinna L.A. Specific substrates and sequences of casein kinase II. J Biol Chem. 259:1984;14576-14580.
9. Robitzky A., Bodenbach L., Voss H., Pyerin W. Human casein kinase II. J Biol Chem. 268:1993;5694-5702.
10. Allende J.F., Allende C.C. Protein kinase 2 An enzyme with multiple substrates and a puzzling regulation . FASEB J. 9:1995;313-323.
11. Vancurova I., Paine T.M., Lou W., Paine W.L. Nucleoplasmin associates with and is phosphorylated by casein kinase II. J Cell Sci. 108:1995;779-787.
12. Gündoǧuş N., Sayilir C., Özalp C., Özkan F., Yücel M., Criss W.E. Effects of polyamine-stimulated casein kinase II from rat brain on cellular oncogene activities. Turk J Med Sci. 23:1996;107-116.
13. Hanks S.K., Quinn A.M. Protein kinase catalytic domain sequence database. Methods Enzymol. 200:1991;38-81.
14. Morshak D.R., Carroll D. Synthetic peptide substrates for casein kinase II. Methods Enzymol. 200:1991;134-156.
15. Roach P.J. Multisite and hierarchal protein phosphorylation. J Biol Chem. 26:1991;14139-14142.
16. Tabor C.W., Tabor H. Polyamines. Annu Rev Biochem. 53:1984;749-790.
17. Pegg A.E. Polyamine metabolism, its importance in neoplastic growth and as a target for chemotherapy. Cancer Res. 48:1988;759-774.
18. Seiler N., Dezeure F. Polyamine transport in mammalian cells. Int J Biochem. 22:1990;211-218.
19. Bergeron R.J., McManis J.S., Liu C.Z., Feng Y., Weimar W.R., Luchetta G.R., Wu Q., Ortiz-Ocasio J., Vison J.R., Kramer D., Porter C. Antiproliferative properties of polyamine analogues A structure-activity study . J Med Chem. 37:1994;3464-3476.
20. 12-bis-(ethyl)-spermine homologues against MALME-3 melanoma xenografts. Cancer Res. 52:1992;2420-2430.
21. 12-bis-(ethyl)-spermine. Cancer Res. 53:1993;2071-2075.
22. Basu H.S., Delhan M., Feuerstein B.G., Shirahata A., Samejima K., Deen D.F., Marton L.J. Interaction of a polyamine analogue, 1,19-bis-(ethylamino)-5,10,15, triazononadecane (BE4-4-4-4) with DNA and its effect on growth, survival, and polyamine levels in seven human brain tumor cell lines. Cancer Res. 53:1993;3948-3955.
23. Criss W.E., Yamamoto M., Takai Y., Nishizuka Y., Morris H.P. Requirements of polycations for enzymatic activity of a new kinase and substrate complex from Morris hepatoma 3924A. Cancer Res. 38:1978;3532-3539.
24. Criss W.E., Yamamoto M., Takai Y., Nishizuka Y., Morris H.P. Resolution and properties of the catalytic component and phosphate acceptor proteins of a new protein kinase substrate complex from Morris hepatoma 3924A. Cancer Res. 38:1978;3540-3545.
25. Yamamoto M., Criss W.E., Takai Y., Yamamura H., Nishizuka Y. A hepatic-soluble cAMP-independent protein kinase stimulated by polyamines. J Biol Chem. 245:1979;5049-5052.
26. Filhot O., Cochet C., Wedegaertner P., Gill G., Chambaz E.M. Coexpression of both alpha and beta subunits is required for assembly of regulated casein kinase II. Biochemistry. 30:1991;11133-11140.
27. Demireller A., Akar C., Criss W.E. Polyamine-dependent protein kinase in human larynx cancer. Turk J Cancer. 21:1991;9-13.
28. Akar C., Criss W.E. A polyamine-dependent casein kinase type 2 in rat brain tissue. Turk J Biochem. 3:1992;1-18.
29. Gündoǧuş-Özcanli N., Criss W.E. Purification of casein kinase II from sheep lung tissue and kinetic evaluations with polyamines and Myc oncoprotein. Turk J Med Sci. 28:1998;599-604.
30. Lüscher B., Kuenzel E.A., Krebs E.G., Eisenman R.N. Myc oncoproteins are phosphorylated by casein kinase II. EMBO J. 8:1989;1111-1119.
31. DePinho R.A., Schreiber A.N., Alt F.W. myc Family of oncogenes in the development of normal and neoplastic cells. Adv Cancer Res. 57:1991;1-46.
32. Marcu K.B., Bossone S.A., Patel A.J. Myc function and regulation. Annu Rev Biochem. 61:1992;809-860.
33. Prins J., DeVries E.G.E., Mulder N.H. The myc family of oncogenes and their presence and importance in small cell lung cancer and other tumor types. Anticancer Res. 13:1993;1373-1386.
34. Lemaitre J.M., Buckle R.S., Mechall M. C-myc in the control of cell proliferation and embryonic development. Adv Cancer Res. 70:1996;97-139.
35. Packham G., Porter C.W., Cleveland J.L. C-myc induces apoptosis and cell cycle progression by separate yet overlapping pathways. Oncogene. 13:1996;461-469.
36. Hesketh R. myc Oncogene. Hesketh R. The Oncogene Facts Book. 1995;201-210 Academic Press, New York.
37. Hesketh R. max Oncogene. Hesketh R. The Oncogene Facts Book. 1995;178-181 Academic Press, New York.
38. Kumagai T., Tanio Y., Osaki T., Hosose S., Tachibana I., Ueno K., Kijima T., Horai T., Kishimoto T. Eradication of myc-overexpressing small cell lung cells transfected with a herpes simplex virus thymidine kinase gene containing myc-max response elements. Cancer Res. 56:1996;354-358.
39. Packham G., Porter C.W., Cleveland J.L. c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways. Oncogene. 13:1996;461-469.
40. Lutz W., Stohr M., Schurmann J., Lohr A., Schwab M. Conditional expression of N-myc in human neuroblastoma cells increases the expression of prothymosis and ornithine decarboxylase and accelerates progression into S phase after mitogenic stimulation of quiescent cells. Oncogene. 13:1996;803-812.
41. 1-cyclin-dependent kinases. Oncogene. 15:1997;649-656.
42. 1 arrest through reduction of cyclin E/CKD2 kinase activity. Oncogene. 15:1997;1347-1356.
43. Mochizuki T., Kitanaka C., Noguchi K., Sugiyama A., Kagaya S., Chui S., Asai A., Kuchino Y. Pim-1 kinase stimulates c-Myc-mediated death signaling upstream of caspase-3 (CPP32)-like protease activation. Oncogene. 15:1997;1471-1480.
44. Hernandez S., Hernandez L., Bea S., Cazorla M., Nadal A., Muntane J., Montserrat E., Cardesa A., Campo E. cdc26 cell cycle activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas. Cancer Res. 58:1998;1762-1767.